Diagnostics and Healthcare

Aging populations and changes in healthcare funding are increasing pressures on healthcare organizations to deliver better patient care at lower cost. New diagnostic technologies can play a critical role by enabling earlier diagnoses and optimizing treatments. Our products support healthcare and laboratory professionals in areas including allergy and immunology, critical care medicine, clinical microbiology, drugs of abuse testing, therapeutic drug monitoring, transplant diagnostics, and anatomical pathology. In a doctor’s office, a hospital, or a reference lab, we are helping to improve patient outcomes and manage costs.



Allergy and Asthma

The more you know about all of your patients' allergic sensitivities, the better you can optimize their management.
Learn more >



Allergy

You do not have to wait for allergy season to do something. Find out what's really behind your allergies.
Learn more >

Sepsis

   

Sepsis is a common and frequently fatal medical condition that is the result of the body’s inflammatory response to an infection. In the US 751,000 severe sepsis cases occurred in 1995 and mortality was 28.6%, or 215,000 deaths nationally. Learn why early identification and intervention is crucial to improving sepsis outcomes on our About Sepsis information page.
Learn more >

Sepsis Identification

Featured video


Automated drugs of abuse analysis

Automated random access benchtop solution for small and medium laboratory settings
Learn more >



To improve monitoring of one of the most commonly prescribed immunosuppressant drugs, tacrolimus, Thermo Fisher Scientific has unveiled the Thermo Scientific QMS Tacroliums Immunoassay.
Read more >

   

QMS Tacro Assay

Latest news


Blood banks are essential links in the healthcare supply chain around the globe. Thermo Fisher Scientific recently installed its 1000th blood banking centrifuge in India at the All India Institute of Medical Sciences in New Delhi.
Read more >

Transplant Diagnostics


One Lambda receives CE mark approval for C1qScreen assay and launches Assay in Europe. The C1qScreen™ assay, which was recently cited in the New England Journal of Medicine for its use in a kidney graft survival study, is now available in all CE mark-conforming countries, enabling European HLA clinics and laboratories to immediately use it during transplant diagnostic procedures.
Read more >